Quote:
Originally Posted by RWebb
Looks like they only tried one interferon, a Beta
|
And may have given it later in disease course. mAb seem to be harmful late, perhaps INF-beta similar.
https://www.nature.com/articles/d41586-020-03070-1
There’s other INF trials ongoing, including an inhaled (nebulized) INF-beta drug from a little UK company, was developing it for COPD I think.